alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 876.5990 Extracorporeal shock wave lithotripter. ( a ) *Identification.* An extracorporeal shock wave lithotripter is a device that focuses ultrasonic shock waves into the body to noninvasively fragment urinary calculi within the kidney or ureter. The primary components of the device are a shock wave generator, high voltage generator, control console, imaging/localization system, and patient table. Prior to treatment, the urinary stone is targeted using either an integral or stand-alone localization/imaging system. Shock waves are typically generated using electrostatic spark discharge (spark gap), electromagnetically repelled membranes, or piezoelectric crystal arrays, and focused onto the stone with either a specially designed reflector, dish, or acoustic lens. The shock waves are created under water within the shock wave generator, and are transferred to the patient's body using an appropriate acoustic interface. After the stone has been fragmented by the focused shock waves, the fragments pass out of the body with the patient's urine.
( b ) *Classification.* Class II (special controls) (FDA guidance document: “Guidance for the Content of Premarket Notifications (510(k)'s) for Extracorporeal Shock Wave Lithotripters Indicated for the Fragmentation of Kidney and Ureteral Calculi.”)
[65 FR 48612, Aug. 9, 2000]
Exhibit 32

CERTIFICATION

The undersigned certify pursuant to 18 U.S.C. § 1350, that:

|    |                                                                                                                                                                                                 
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|(1) | The
 accompanying Quarterly Report on Form 10-Q for the period ended April 30,
 2009 fully complies with the requirements of Section 13(a) or 15(d) of the
 Securities Exchange Act of 1934; and
|    |                                                                                                                                                                                                 
|(2) | The
 information contained in the accompanying Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.                            

|      |               |  |                                        |                     | 
|----- | ------------- |  | -------------------------------------- | ------------------- | 
|Date: | June 12, 2009 |  |                                        | /s/ Rodney A. Young | 
|      |               |  | President and
 Chief Executive Officer

|      |               |  |                          |                         | 
|----- | ------------- |  | ------------------------ | ----------------------- | 
|Date: | June 12, 2009 |  |                          | /s/ William J. Kullback | 
|      |               |  | Chief
 Financial Officer

24

---
§ 1.171-4 Election to amortize bond premium on taxable bonds. ( a ) *Time and manner of making the election* — ( 1 ) *In general.* A holder makes the election to amortize bond premium by offsetting interest income with bond premium in the holder's timely filed federal income tax return for the first taxable year to which the holder desires the election to apply. The holder should attach to the return a statement that the holder is making the election under this section.
( 2 ) *Coordination with OID election.* If a holder makes an election under § 1.1272-3 for a bond with bond premium, the holder is deemed to have made the election under this section.
( b ) *Scope of election.* The election under this section applies to all taxable bonds held during or after the taxable year for which the election is made.
( c ) *Election to amortize made in a subsequent taxable year* — ( 1 ) *In general.* If a holder elects to amortize bond premium and holds a taxable bond acquired before the taxable year for which the election is made, the holder may not amortize amounts that would have been amortized in prior taxable years had an election been in effect for those prior years.
( 2 ) *Example.* The following example illustrates the rule of this paragraph (c): Example. (i) *Facts.* On May 1, 1999, C purchases for $130,000 a taxable bond maturing on May 1, 2006, with a stated principal amount of $100,000, payable at maturity. The bond provides for unconditional payments of interest of $15,000, payable on May 1 of each year. C uses the cash receipts and disbursements method of accounting and the calendar year as its taxable year. C has not previously elected to amortize bond premium, but does so for 2002. (ii) *Amount to amortize.* C's basis for determining loss on the sale or exchange of the bond is $130,000. Thus, under § 1.171-1, the amount of bond premium is $30,000. Under § 1.171-2, if a bond premium election were in effect for the prior taxable years, C would have amortized $3,257.44 of bond premium on May 1, 2000, and $3,551.68 of bond premium on May 1, 2001, based on annual accrual periods ending on May 1. Thus, for 2002 and future years to which the election applies, C may amortize only $23,190.88 ($30,000−$3,257.44−$3,551.68).
( d ) *Revocation of election.* The election under this section may not be revoked unless approved by the Commissioner. Because a revocation of the election is a change in accounting method, a taxpayer must follow the rules under § 1.446-1(e)(3)(i) to request the Commissioner's consent to revoke the election. A revocation of the election applies to all taxable bonds held during or after the taxable year for which the revocation is effective. The holder may not amortize any remaining bond premium on bonds held at the beginning of the taxable year for which the revocation is effective. Therefore, no adjustment under section 481 is allowed upon the revocation of the election because no items of income or deduction are omitted or duplicated.
[T.D. 8746, 62 FR 68182, Dec. 31, 1997]
(logo)****CURCIO

+COHEN

 

 

**Report of IndependentRegistered Public Accounting Firm**

 

Managing Member

Park Bridge Lender ServicesLLC

New York, NY

 

 

We have examinedmanagement’s assertion, included in the accompanying Management’sReport on Assessment of 2016 Compliance by Park Bridge Lender Services LLC withRegulation AB Servicing Criteria (“Management’s Report”),that Park Bridge Lender Services LLC (the “Company”) complied withthe servicing criteria set forth in Item 1122(d) of the U.S. Securities andExchange Commission’s Regulation AB as of and for the year ended December31, 2016, excluding those criteria noted as not applicable (N/A) within ExhibitB to Management’s Report. The transactions covered by this report areonly those transactions processed by the Company in its capacity as trustadvisor or operating advisor for the asset backed securities transactions (the“Platform”) identified in Management’s Report. ReferenceExhibit A to Management’s Report for the transactions covered by thisexamination. Management is responsible for the Company’s compliance withthe applicable servicing criteria. Our responsibility is to express an opinionon management’s assertion based on our examination.

 

Our examination was conductedin accordance with attestation standards of the Public Company AccountingOversight Board (United States) and, accordingly, included examining, on a testbasis, evidence about the Company’s compliance with the applicableservicing criteria and performing such other procedures as we considered necessaryin the circumstances. Our examination included testing of a selected sample ofthe servicing activities related to the Platform, determining whether theCompany performed those selected activities in compliance with the applicableservicing criteria during the specified period. Our procedures were limited tothe selected transactions and servicing activities performed by the Companyduring the period covered by this report. Our examination was not designed todetect material noncompliance arising from errors that may have occurred priorto or subsequent to our tests, that may have affected the Company’sservicing activities during the period covered by this report. We believe thatour examination provides a reasonable basis for our opinion. Our examinationdoes not provide a legal determination on the Company’s compliance withthe applicable servicing criteria.

 

In our opinion,management’s assertion that the Company complied with the aforementionedapplicable servicing criteria identified in Exhibit B to Management’sReport with respect to the transactions identified in Exhibit A toManagement’s Report as of and for the year ended December 31, 2016, forthe Platform, is fairly stated in all material aspects.

 

 

/s/ Curcio & Cohen,CPA’s, P.C.

 

 

New York, NY

February 2, 2017

 

 

CERTIFIED PUBLIC ACCOUNTANTSPC 7 PENN PLAZA, SUITE 1500 NEW YORK NY 10001

TEL: 212 557-9800  FAX:212 557 9819   WEBSITE: WWW.CWCCPAFIRM.COM
Slip Op. 99-115 UNITED STATES COURT OF INTERNATIONAL TRADE BEFORE: SENIOR JUDGE NICHOLAS TSOUCALAS

___________________________________ : SKF USA INC., SKF FRANCE S.A. : and SARMA, : : Plaintiffs, : : v. : Consol. Court No. : 97-01-00054 THE UNITED STATES, : : Defendant, : : THE TORRINGTON COMPANY, : : Defendant-Intervenor. : ___________________________________: JUDGMENT This Court having received and reviewed the United States Department of Commerce, International Trade Administration’s (“Commerce”) Final Results of Redetermination Pursuant to Court Remand, SKF USA Inc. v. United States , 23 CIT __, Slip Op. 99-56 (June 29, 1999) (“Remand Results”), and Commerce having complied with the Court’s remand, and no responses to the Remand Results having been submitted by the parties, it is hereby ORDERED that the Remand Results filed by Commerce on September 10, 1999 are affirmed in their entirety; and it is further ORDERED that since all other issues have been decided, this case is dismissed.

______________________________ NICHOLAS TSOUCALAS SENIOR JUDGE

Dated: October 28, 1999 New York, New York
# ----**-- ---** **~S ------** **---** May 14 , 2015 The Honorable Anthony 

### R. Foxx Secretary of Transportation US Department of Transportation 1200 New Jersey Avenue SE Washington , DC 20590 The Honorable John F

. Kerry Secretary of State US Department of State 2201 C Street NW Washington , DC 20520 The Honorable Penny Pritzker Secretary of Commerce US Department of Commerce 1401 Constitution Avenue NW Washington , DC 20230 Dear Secretaries Kerry , Foxx and Pritzker: I am writing to express my concern with growing evidence documenting unfair practices of the governments of Qatar and the United Arab Emirates (UAE)

. Over the past decade, Qatar Airways , Etihad Airways and Emirates Airline have undermined U

. S. airlines by receiving at least $42 billion in government subsidies and other unfair benefits in violation of U.S. Open Skies policy

. This is helping Gulf carriers to drive down ticket prices and contributes to excess capacity, both of which will decrease revenue and load factors for U

. S

. airlines

. These actions, if left unchecked, will result in service cuts, job losses and slower economic development in our region

. As a hub and international gateway for American Airlines , Charlotte Douglas International Airport (CL T) contributes nearly $10 billion to our local economy each year
. American employs nearly 10,000 people at CLT with over 725 daily flights and carries more than 43.5 million passengers annually. CLT is vital to our members , business owners and our community as a whole

. 1 urge the U.S. government to open consultations with Qatar and UAE in ord erlOaddress the flow of subsidized capacity into the U

. S. market. In addition , the U

. S. government should freeze the introduction of new passenger service by the gulf carriers during these consultations

. Thank you for your attention to this matter.

# ~I Bob Morgan President and CEO Charlotte Chamber of Commerce
cc : Senator Richard Burr Senator Thom Tillis 

### S1U - 150520-017 : ox 327 8 5 1 Cha rl otte, N C 28232 1 Phone : 704.378.13 00 1 Fax : 7 04.374. 1 903 I cha rl ottech amber.com

# charlot_t§L**CHAMBE t**  330 S. T ryon Street P.O

. Box 32785 Charlotte, NC 28232-2785 www.charlottechamber.com



# s 10-150520-017 CHARLCiTTE NC262 14**~1.,~Y '~LS**  

### PM 5 L



### The Honorable Anthony R. Foxx Secretary of Transportation US Department of Transportation 1200 New Jersey Avenue SE Washington , DC 20590 

# II**Qt{;-~-¢f'%.1;>«' uz~**  

# ,_

-**·- ~**  

# - -----**~ ~**  nn 4 1v nows:_s 0 2 1 M 

## $ 

# 00.48° 0004286 7 83 MAY1 4 20 1 5 MAILED FROM ZIPCODE 28202
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM THE BALANCE
SHEET AS OF SEPTEMBER 30, 2000 AND FROM THE STATEMENT OF OPERATIONS FOR THE NINE
MONTHS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                                            <C>
<PERIOD-TYPE>                                  9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                         474,649
<SECURITIES>                                   0
<RECEIVABLES>                                  16,895
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0<F1>
<PP&E>                                         9,462,999
<DEPRECIATION>                                 0<F2>
<TOTAL-ASSETS>                                 10,097,490
<CURRENT-LIABILITIES>                          0<F1>
<BONDS>                                        4,667,088
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     5,165,517
<TOTAL-LIABILITY-AND-EQUITY>                   10,097,490
<SALES>                                        1,431,741
<TOTAL-REVENUES>                               1,460,679
<CGS>                                          0
<TOTAL-COSTS>                                  1,190,174
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             270,724
<INCOME-PRETAX>                                (219)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (219)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (219)
<EPS-BASIC>                                    0
<EPS-DILUTED>                                  0
<FN>
<F1> THE PARTNERSHIP HAS AN UNCLASSIFIED BALANCE SHEET, THEREFORE THE BALANCE IS
$0.
<F2> THIS INFORMATION IS NOT DISCLOSED  IN  THE  PARTNERSHIP'S FORM 10-Q FILING.
</FN>



</TABLE>
Exhibit 32.1

STATEMENT OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Form 10-Q of Hilb Rogal & Hobbs Company for the quarter ended June 30, 2008, I, Martin L. Vaughan, III, Chairman and
Chief Executive Officer of Hilb Rogal & Hobbs Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) such Form 10-Q for the quarter ended June 30, 2008 fully complies with the requirements of section 13(a) of the Securities
Exchange Act of 1934, as amended; and

(b) the information contained in such Form 10-Q for the quarter ended June 30,
2008 fairly presents, in all material respects, the consolidated financial condition and results of operations of Hilb Rogal & Hobbs Company and its subsidiaries as of and for the periods presented in such Form 10-Q.



|    |  |                                      |  |  |  |                     
|--- |  | ------------------------------------ |  |  |  | --------------------
|By: |  | /s/    MARTIN L. VAUGHAN,
III        |  |  |  | Date: August 7, 2008
|    |  | Martin L. Vaughan, III               |  |  |  |                     
|    |  | Chairman and Chief Executive Officer |  |  |  |
- unified-agenda-template-2-cover version 2b
- unified-agenda-template-2-intro
- regulatory-reduction
- unified-agenda-template-reg-examples-1-2
- unified-agenda-template-reg-examples-3-4
- looking-ahead
- backcover v2
EXHIBIT 10.16

Schedule 10.16 identifying  contracts that are substantially  similar to Exhibit
10.15 in all material  respects except as to the parties  thereto,  the dates of
execution and the loan amount.

---------------------------------------- --------------------------------------
DATE                                     LOAN AMOUNT
---------------------------------------- --------------------------------------
December 1, 2001                         $25,000*
---------------------------------------- --------------------------------------
December 3, 2001                         $25,000*
---------------------------------------- --------------------------------------
December 7, 2001                         $25,000*
---------------------------------------- --------------------------------------
December 3, 2001                         $25,000
---------------------------------------- --------------------------------------
December 6, 2001                         $25,000
---------------------------------------- --------------------------------------
December 12, 2001                        $25,000
---------------------------------------- --------------------------------------
December 19, 2001                        $25,000
---------------------------------------- --------------------------------------
December 26, 2001                        $25,000
---------------------------------------- --------------------------------------
December 26, 2001                        $25,000
---------------------------------------- --------------------------------------
January 4, 2002                          $25,000
---------------------------------------- --------------------------------------
January 21, 2002                         $25,000
---------------------------------------- --------------------------------------
February 11, 2002                        $25,000
---------------------------------------- --------------------------------------
February 14, 2002                        $25,000
---------------------------------------- --------------------------------------
*Note repaid







                                       59
Editorial Note on Part 874
Editorial Note: Nomenclature changes to part 874 appear at 73 FR 35341, June 23, 2008.

§ 874.3820 Endolymphatic shunt. ( a ) *Identification.* An endolymphatic shunt is a device that consists of a tube or sheet intended to be implanted to relieve the symptons of vertigo. The device permits the unrestricted flow of excess endolymph from the distended end of the endolymphatic system into the mastoid cavity where resorption occurs. This device is made of polytetrafluoroethylene or silicone elastomer.
( b ) *Classification.* Class II.
# C_2014303EN.01004801.xml

| 8.9.2014 | EN | Official Journal of the European Union | C 303/48 |
| --- | --- | --- | --- |

8.9.2014

EN

Official Journal of the European Union

C 303/48

---

Action brought on 7 July 2014 — GreenPack v OHIM (greenpack)

(Case T-513/14)

2014/C 303/56

Language of the case: German

Parties

Parties

Applicant: GreenPack GmbH (Henningsdorf, Germany) (represented by P. Ruess und A. Doepner-Thiele, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 29 April 2014 in Case R 2324/2013-1; |
| --- | --- |

—

annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 29 April 2014 in Case R 2324/2013-1;

| — | order OHIM to pay the costs. |
| --- | --- |

—

order OHIM to pay the costs.

Pleas in law and main arguments

Pleas in law and main arguments

Community trade mark concerned: Word mark ‘greenpack’ for goods and services in Class 9 — Community trade mark application No 1 1 9 26  706

Community trade mark concerned:

Decision of the Examiner: Refused the application

Decision of the Examiner:

Decision of the Board of Appeal: Rejected the appeal

Decision of the Board of Appeal:

Pleas in law:

Pleas in law:

| — | Infringement of Article 7(1)(b) of Regulation No. 207/2009 |
| --- | --- |

—

Infringement of Article 7(1)(b) of Regulation No. 207/2009

| — | Infringement of Article 7(1)(c) of Regulation No. 207/2009 |
| --- | --- |

—

Infringement of Article 7(1)(c) of Regulation No. 207/2009

---
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.5300 Ultrasonic diathermy. ( a ) *Ultrasonic diathermy for use in applying therapeutic deep heat for selected medical conditions* — ( 1 ) *Identification.* An ultrasonic diathermy for use in applying therapeutic deep heat for selected medical conditions is a device that applies to specific areas of the body ultrasonic energy at a frequency beyond 20 kilohertz and that is intended to generate deep heat within body tissues for the treatment of selected medical conditions such as relief of pain, muscle spasms, and joint contractures, but not for the treatment of malignancies.
( 2 ) *Classification.* Class II (performance standards).
( b ) *Ultrasonic diathermy for all other uses* — ( 1 ) *Identification.* An ultrasonic diathermy for all other uses except for the treatment of malignancies is a device that applies to the body ultrasonic energy at a frequency beyond 20 kilohertz and that is intended for the treatment of medical conditions by means other than the generation of deep heat within body tissues as described in paragraph (a) of this section.
( 2 ) *Classification.* Class III (premarket approval).
( c ) *Date PMA or notice of completion of PDP is required.* A PMA or notice of completion of a PDP for a device described in paragraph (b) of this section is required to be filed with the Food and Drug Administration on or before July 13, 1999, for any ultrasonic diathermy described in paragraph (b) of this section that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to an ultrasonic diathermy described in paragraph (b) of this section that was in commercial distribution before May 28, 1976. Any other ultrasonic diathermy described in paragraph (b) of this section shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
[48 FR 53047, Nov. 23, 1983, as amended at 52 FR 17742, May 11, 1987; 64 FR 18331, Apr. 14, 1999]